IceCure Medical (ICCM) Receivables - Net (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Receivables - Net data on file, last reported at $274000.0 in Q1 2026.

• On a quarterly basis, Receivables - Net fell 8.67% year-over-year to $274000.0 in Q1 2026; TTM through Mar 2026 was $274000.0, a 8.67% decrease from a year earlier, with the FY2025 full-year figure at $331000.0, up 49.77% from the prior year.
• Receivables - Net for Q1 2026 stood at $274000.0, down from $331000.0 in the prior quarter.
• Over the last five years, Receivables - Net for ICCM reached as high as $78.0 million in Q4 2022 and fell as low as $103000.0 in Q4 2023.
• Historically, Receivables - Net has averaged $4.8 million across 5 years, with a median of $184000.0 in 2022.
• Across the five-year window, Receivables - Net surged 17005.26% in 2022 and tumbled 99.87% in 2023, its largest moves.
• Year by year, Receivables - Net stood at $78.0 million in 2022, then tumbled by 99.87% to $103000.0 in 2023, then soared by 114.56% to $221000.0 in 2024, then soared by 49.77% to $331000.0 in 2025, then declined by 17.22% to $274000.0 in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $274000.0 in Q1 2026, $331000.0 in Q4 2025, and $104000.0 in Q3 2025.